Drs. Gregory Simon, Neeraj Mistry, and Peter Hotez's article on NTD impact on child health appeared in the BMJ journal
Sabin President Dr. Peter Hotez's latest editorial, titled “Campaign Spending: What Else Can $2 Billion Buy?” was recently published in the Huffington Post. The editorial discusses how the amount of money spent on this year’s presidential campaign could have also been used to treat and control NTDs in various regions around the world.
See the original article in the Huffington Post here.
The open-access journal, PLoS NTDs, celebrated its fifth anniversary. To commemorate this great achievement, the journal compiled editorials and research papers published over the last five years to create a collection, called “The Geopolitics of NTDs.”
The collection focuses on the geographic distribution of NTDs by region to highlight the key differences as well as similarities between the diseases in different areas around the world.
October 11, 2012 | Financial Times
The Financial Times special report “Combating Neglected Diseases” contains in-depth stories and interviews featuring several of Sabin’s key programs, including Sabin Vaccine Development, the Global Network for Neglected Tropical Diseases and the Dengue Vaccine Initiative.
Read the full report here.
Last Friday, Sabin president Dr. Peter Hotez was a featured guest on Soledad O’Brien’s CNN morning show “Starting Point.” On the show, Dr. Hotez discussed the burden of neglected tropical diseases (NTDs) globally and closer to home in the United States.
May 18, 2012 | Pacific Standard
Ahead of this weekend’s G8 Summit, Dr. Peter Hotez wrote an op-ed for Pacific Standard calling on G8 leaders to focus on NTD treatment and control as a cost-effective method to improve global health.
Reversing the World’s Neglect of Easily Cured Tropical Diseases
Dr. Peter Hotez
February 17, 2012
January 19, 2012 | The Atlantic
By Peter Hotez and James Kazura
Jan 19 2012, 8:06 AM ET
As long as we have a military presence in areas known for infectious diseases, we have to keep researchers working on improved treatments.